Literature DB >> 24306130

Analysis of quinolone-resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru.

Maria J Pons1, S Mosquito, C Gomes, L J Del Valle, T J Ochoa, J Ruiz.   

Abstract

BACKGROUND: Antibiotic resistance is an increasing problem, particularly in countries where antibiotic use is frequently not controlled. The aim of this study was to analyse the prevalence of the molecular mechanisms of quinolone-resistance in E. coli isolated from faeces of healthy Peruvian children or those presenting diarrhoea.
METHODS: The presence of target mutations, transferable quinolone-resistance mechanisms and the role of Phe-Arg-β-Naphtylamyde inhibitible efflux pumps were studied in 96 Escherichia coli (46 diarrheogenic and 50 non-diarrheogenic) isolates exhibiting resistance or diminished susceptibility to quinolones.
RESULTS: The most resistant phenotype, Nal(R) and Cip(R), was most frequently present in isolates of healthy children. The distribution of quinolone resistance mechanisms between diarrheogenic (DEC) and commensal (non DEC) isolates was equitable, although the aac(6')Ib-cr gene was mainly detected in DEC isolates: 17 (34%) vs non DEC isolates nine (20%). QnrB was present in five (10%) DEC vs three (6%) non DEC isolates.
CONCLUSIONS: Point mutations in gyrA and parC genes play a relevant role in quinolone resistance acquisition and highlight the role of efflux pumps also. This study provides knowledge about the molecular mechanisms involved in quinolone resistance in isolates in a non exposed population under high community antibiotic pressure.

Entities:  

Keywords:  Antibiotic resistance; Children; Commensal; Developing countries; Diarrheogenic Escherichia coli; Quinolones

Mesh:

Substances:

Year:  2013        PMID: 24306130      PMCID: PMC3871486          DOI: 10.1093/trstmh/trt106

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  30 in total

1.  Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates.

Authors:  Anna Ribera; Joaquim Ruiz; M Teresa Jiminez de Anta; Jordi Vila
Journal:  J Antimicrob Chemother       Date:  2002-04       Impact factor: 5.790

2.  [Trends in antimicrobial utilization in a university hospital, 1990-1996].

Authors:  Mauro Silveira de Castro; Diogo Pilger; Maria Beatriz Cardoso Ferreira; Luciane Kopittke
Journal:  Rev Saude Publica       Date:  2002-12-02       Impact factor: 2.106

3.  QnrVC, a new transferable Qnr-like family.

Authors:  Maria J Pons; Cláudia Gomes; Joaquim Ruiz
Journal:  Enferm Infecc Microbiol Clin       Date:  2012-10-23       Impact factor: 1.731

4.  Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries.

Authors:  S Nys; I N Okeke; S Kariuki; G J Dinant; C Driessen; E E Stobberingh
Journal:  J Antimicrob Chemother       Date:  2004-10-07       Impact factor: 5.790

5.  Pediatric uses of fluoroquinolone antibiotics.

Authors:  Thomas S Murray; Robert S Baltimore
Journal:  Pediatr Ann       Date:  2007-06       Impact factor: 1.132

6.  Age-related susceptibility to infection with diarrheagenic Escherichia coli among infants from Periurban areas in Lima, Peru.

Authors:  Theresa J Ochoa; Lucie Ecker; Francesca Barletta; Mónica L Mispireta; Ana I Gil; Carmen Contreras; Margarita Molina; Isabel Amemiya; Hector Verastegui; Eric R Hall; Thomas G Cleary; Claudio F Lanata
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

Review 7.  Plasmid-mediated quinolone resistance: a multifaceted threat.

Authors:  Jacob Strahilevitz; George A Jacoby; David C Hooper; Ari Robicsek
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

8.  Antibiotic prescribing in two private sector hospitals; one teaching and one non-teaching: a cross-sectional study in Ujjain, India.

Authors:  Megha Sharma; Bo Eriksson; Gaetano Marrone; Suryaprakash Dhaneria; Cecilia Stålsby Lundborg
Journal:  BMC Infect Dis       Date:  2012-07-12       Impact factor: 3.090

9.  Plasmid-Mediated Quinolone Resistance; Interactions between Human, Animal, and Environmental Ecologies.

Authors:  Laurent Poirel; Vincent Cattoir; Patrice Nordmann
Journal:  Front Microbiol       Date:  2012-02-02       Impact factor: 5.640

Review 10.  Emerging mechanisms of fluoroquinolone resistance.

Authors:  D C Hooper
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more
  17 in total

1.  Comparative analysis of antimicrobial resistance in enterotoxigenic Escherichia coli isolates from two paediatric cohort studies in Lima, Peru.

Authors:  Anicia M Medina; Fulton P Rivera; Maria J Pons; Maribel Riveros; Cláudia Gomes; María Bernal; Rina Meza; Ryan C Maves; Luis Huicho; Elsa Chea-Woo; Claudio F Lanata; Ana I Gil; Theresa J Ochoa; Joaquim Ruiz
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-08       Impact factor: 2.184

2.  Genetic Relatedness Among Escherichia coli Pathotypes Isolated from Food Products for Human Consumption in Cartagena, Colombia.

Authors:  Zorangel Amézquita-Montes; Maria Tamborski; Usa G Kopsombut; Chengxian Zhang; Octavio S Arzuza; Oscar G Gómez-Duarte
Journal:  Foodborne Pathog Dis       Date:  2015-03-18       Impact factor: 3.171

Review 3.  Transferable Mechanisms of Quinolone Resistance from 1998 Onward.

Authors:  Joaquim Ruiz
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

4.  Antibiotic-Resistant Escherichia coli in Drinking Water Samples from Rural Andean Households in Cajamarca, Peru.

Authors:  Anika Larson; Stella Maria Hartinger; Maribel Riveros; Gabriela Salmon-Mulanovich; Jan Hattendorf; Hector Verastegui; Maria Luisa Huaylinos; Daniel Mäusezahl
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

5.  Antimicrobial Resistance in Humans, Animals, Water and Household Environs in Rural Andean Peru: Exploring Dissemination Pathways through the One Health Lens.

Authors:  Stella M Hartinger; Maria Luisa Medina-Pizzali; Gabriela Salmon-Mulanovich; Anika J Larson; María Pinedo-Bardales; Hector Verastegui; Maribel Riberos; Daniel Mäusezahl
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

6.  Comparative analysis of quinolone resistance in clinical isolates of Klebsiella pneumoniae and Escherichia coli from Chinese children and adults.

Authors:  Ying Huang; James O Ogutu; Jiarui Gu; Fengshu Ding; Yuhong You; Yan Huo; Hong Zhao; Wenjing Li; Zhiwei Zhang; Wenli Zhang; Xiaobei Chen; Yingmei Fu; Fengmin Zhang
Journal:  Biomed Res Int       Date:  2015-02-10       Impact factor: 3.411

7.  Temporal Variability of Escherichia coli Diversity in the Gastrointestinal Tracts of Tanzanian Children with and without Exposure to Antibiotics.

Authors:  Taylor K S Richter; Tracy H Hazen; Diana Lam; Christian L Coles; Jessica C Seidman; Yaqi You; Ellen K Silbergeld; Claire M Fraser; David A Rasko
Journal:  mSphere       Date:  2018-11-07       Impact factor: 4.389

8.  Nosocomial Infections: Multicenter surveillance of antimicrobial resistance profile of Staphylococcus aureus and Gram negative rods isolated from blood and other sterile body fluids in Iran.

Authors:  Bahman Poorabbas; Jalal Mardaneh; Zahra Rezaei; Mehdi Kalani; Gholamreza Pouladfar; Mohammad Hasan Alami; Jafar Soltani; Ahmad Shamsi-Zadeh; Shahram Abdoli-Oskooi; Mohammed Jafar Saffar; Abdolvahab Alborzi
Journal:  Iran J Microbiol       Date:  2015-06

9.  Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants.

Authors:  Cláudia Gomes; Sandra Martínez-Puchol; Lidia Ruiz-Roldán; Maria J Pons; Juana Del Valle Mendoza; Joaquim Ruiz
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

Review 10.  Faecal carriage of antibiotic resistant Escherichia coli in asymptomatic children and associations with primary care antibiotic prescribing: a systematic review and meta-analysis.

Authors:  Ashley Bryce; Céire Costelloe; Claire Hawcroft; Mandy Wootton; Alastair D Hay
Journal:  BMC Infect Dis       Date:  2016-07-25       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.